APOD and coronary artery disorder: Our proteomics study also confirmed that levels of lipoprotein APOA2, which is CHD protective, are up-regulated, while levels of APOD are down-regulated and apolipoprotein A (LPA) not changed, in accordance with previous findings from the WHI study [51].